➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Colorcon
Medtronic
Baxter
Merck

Last Updated: December 3, 2020

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

Docket   Start Trial Date Filed 2011-02-22
Court District Court, N.D. California Date Terminated 2013-11-01
Cause 35:271 Patent Infringement Assigned To Joseph C. Spero
Jury Demand None Referred To Jacqueline Scott Corley
Parties PAR PHARMACEUTICAL, INC.
Patents 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755; RE42,461
Attorneys Ryan W. Koppelman
Firms Crowell & Moring, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-04-11 106 following Takeda patents are at issue in the Actions: 1) U.S. Patent No. 6,462,058 (“the … 14 ’058 Patent”); 2) U.S. Patent No. 6,664,276 (“the ’276 Patent”); 3) U.S. Patent No. 6,939,971… 15 ’971 Patent”); 4) U.S. Patent No. 7,737,282 (“the ’282 Patent”); 5) U.S. Patent No. 7,285,668… 16 ’668 Patent”) and 6) U.S. Patent No. 7,790,755 (“the ’755 Patent”). … pharmaceutical patent, even if it is not in the same patent family as the ’282 patent. Id. at 7-8. External link to document
2013-04-30 282 5 Noninfringement Of U.S. Patent No. 7,790,755 Under Fed. R. Civ. P. 54(b) (“the Motion… Here, the court‟s determination that the „755 Patent has not been infringed is a final …a final judgment of noninfringement of the „755 Patent 6 under Rule… 7 the „755 Patent will “streamline the ensuing litigation.” See Hildes…of final judgment of noninfringmenet of the „755 Patent, the Federal Circuit will be required to External link to document
2011-04-29 30 record and assignee of U.S. Patent No. 6,462,058 (“the ‘058 Patent”), U.S. Patent No. … to be a copy of United States Patent No. 6,462,058 (“the ‘058 Patent”) titled “Benzimidazole 15 Compound…22 (Patent Infringement of U.S. Patent No. 6,462,058) 23 37. Handa… (Declaratory Judgment as to U.S. Patent Nos. 6,462,058, 6,664,576, …infringe 13 any valid claim of United States Patent Nos. 6,462,058, 6,664,276, 6,939,971, 7,285,668, and 14 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
McKesson
McKinsey
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.